Clinical Trials · NCT06734312
MAINTAIN (Mucosal AblatIoN Therapy After INcretins)
- Phase
- N/A
- Recruitment status
- Recruiting
- Sponsor
- Dr. Christopher McGowan
- Enrollment
- 20
- Start date
- Jan 2025
- Locations
- 2 sites, United States
- Primary endpoint
- Percent Change in Total Body Weight Loss (TBWL) from Baseline